 It relies on the All Wales Medicines Strategy Group which has appraised and recommended 19 new cancer medicines for use in NHS Wales covering 23 clinical indications.These are now routinely available to eligible patients in Wales but only 9 are available in England via the Cancer Drugs Fund.In May 2015 it was reported that only 59 of the 84 treatments previously funded would be supported in future, and that three new drugs would be included in the scheme.